Kala Bio, Inc. · MUN:27F

Kala Bio, Inc. financial statements

Kala Bio, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue0003.89M11.2M6.36M6.07M000
Cost of revenue317.0K259.0K303.0K2.56M4.10M3.17M2.85M955.0K643.0K297.0K
Gross profit-317.0K-259.0K-303.0K1.33M7.14M3.19M3.23M-955.0K-643.0K-297.0K
Research and development18.8M22.1M18.6M17.7M11.5M18.4M27.3M29.3M29.0M25.0M
Selling, general and administrative23.6M18.3M20.6M65.0M105.1M81.1M65.0M35.4M10.9M7.64M
Operating income-39.2M-41.0M-39.7M-81.7M-130.2M-96.2M-88.2M-64.7M-39.9M-32.7M
Depreciation and amortization317.0K259.0K303.0K537.0K975.0K912.0K843.0K352.0K287.0K297.0K
EBITDA-38.8M-40.7M-39.4M-81.2M-129.3M-95.3M-87.4M-64.4M-39.6M-32.4M
Interest expense3.28M5.78M5.81M7.27M8.38M8.59M8.48M3.31M1.02M767.0K
Income before tax-27.0M-38.5M-42.2M-44.8M-142.6M-104.3M-94.3M-66.7M-42.2M-33.2M
Income tax0000000000
Net income-27.0M-38.5M-42.2M-44.8M-142.6M-104.3M-94.3M-66.7M-42.2M-33.2M
Earnings per share, basic-3.31-10.15-17.35-29.48-108.32-1.99-2.76-2.49-3.71-28.07
Earnings per share, diluted-3.31-10.15-17.35-29.48-108.32-1.99-2.76-2.49-3.71-28.07

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents7.56M51.2M50.9M70.5M92.1M77.3M85.4M170.9M114.6M45.5M
Short-term investments076.3M699.0K0
Receivables236.0K195.0K15.3M9.60M11.6M1.03M
Inventory7.67M8.64M5.23M4.65M4.09M0
Current assets9.49M52.8M52.9M85.9M124.4M171.4M105.5M177.0M115.2M45.6M
Property, plant and equipment749.0K753.0K400.0K2.72M3.17M2.70M2.17M786.0K594.0K
Goodwill0
Total assets9.49M55.5M55.9M86.8M139.4M221.6M154.3M221.0M116.5M46.3M
Accounts payable986.0K628.0K919.0K2.83M4.90M1.72M2.52M5.45M1.20M997.0K
Current liabilities2.49M17.0M8.35M25.7M37.4M22.2M24.8M17.0M14.9M5.55M
Long-term debt20.1M34.2M37.9M78.9M72.2M71.2M70.2M12.0M9.10M
Total debt29.3M34.0M43.3M80.0M75.0M75.0M75.0M18.9M9.65M
Total liabilities2.49M43.2M48.4M67.8M122.6M121.6M124.6M116.0M26.9M15.7M
Shareholders' equity7.00M12.3M7.50M19.0M16.8M100.0M29.7M105.0M89.7M-87.8M
Shares outstanding557.0K6.09M2.76M1.71M1.32M58.9M36.1M33.9M24.5M1.18M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations-32.0M-29.4M-27.9M-78.9M-108.2M-90.7M-92.7M-54.1M-34.1M-27.3M
Capital spending-15.0K-208.0K-610.0K-313.0K-886.0K-1.94M-1.33M-1.58M-480.0K-153.0K
Free cash flow-32.0M-29.6M-28.5M-79.2M-109.1M-92.6M-94.1M-55.7M-34.6M-27.5M
Cash from investing-15.0K-208.0K-429.0K62.7M70.8M-78.2M-1.33M-1.58M-480.0K-153.0K
Cash from financing-11.6M29.9M8.51M-7.94M42.6M160.6M8.98M124.1M103.7M67.2M
Dividends paid-365.0K0
Share buybacks365.0K1.58M160.7M9.01M71.3M97.1M67.9M
Change in cash-43.6M286.0K-19.9M-24.1M5.12M-8.28M-85.1M68.4M69.1M39.7M